No one should ignore even a sharp tooth,” cautioned N. Mahathi, Professor, Oral Oncology and Maxillofacial Surgery, and a representative of the Isha Foundation. To support holistic recovery ...

and effects of cancer treatment. Vision: We will be a world-class center in oral and maxillofacial medicine, radiology, and pathology. We will accomplish this through innovative education, research, ...

Antibody drugs that target the PD-1 and VEGF pathways are in the ASCO spotlight, while doctors wrestle with how to use new ...

Some 10 million people in the U.S. have oral premalignant disease, a group of diseases that show up as red patches, white ...

Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related deaths, and early detection is key to improving patient outcomes. However, the mechanisms driving the transition from ...

Recent years have witnessed a significant shift in our understanding of oral cancer causes. While tobacco and alcohol have traditionally dominated the conversation around risk factors, medical ...

Clinical-stage biopharmaceutical venture OmRx Oncology (OmRx) has commenced a randomised Phase II clinical trial for its oral programmed death ligand 1(PD-L1) inhibitor, OX-4224, targeting ...

June 12th – – Updated dataset to be presented in oral presentation at EHA2025 Congress – SAN DIEGO and TOKYO, May 14, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ...

Vepdegestrant, an oral PROTAC, nearly doubles progression-free survival in ESR1-mutated, ER-positive advanced breast cancer, ...

Positive results from this trial could also pave the way for broader global development, including in high-income countries, where OmRx aims to explore innovative, all-oral immuno-oncology ...

In the domain of oral health research, recent progress has underscored the important role of the oral microbiome in ...

Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like ...